{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:07:24Z","timestamp":1793444844194,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1023\/a:1010686204736","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T22:31:49Z","timestamp":1040596309000},"page":"239-248","source":"Crossref","is-referenced-by-count":185,"title":["Oral Gossypol in the Treatment of Patients with Refractory Metastatic Breast Cancer: A Phase I\/II Clinical Trial"],"prefix":"10.1007","volume":"66","author":[{"given":"Catherine","family":"Van Poznak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus M.","family":"Reidenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Moasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Sklarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Van Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gollub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Bacotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T-J","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renny","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ligueros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sonenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Hudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"337387_CR1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0026-895X(25)11049-3","volume":"37","author":"CC Benz","year":"1990","unstructured":"Benz CC, Keniry MA, Ford JM, Townsend AJ, Cox FW, Palayoor S, Matlin SA, Hait WN, Cowan KH: Biochemical correlates of the anti-tumor and anti-mitochondrial properties of gossypol enantiomers. Mol Pharmacol 37: 840-847, 1990","journal-title":"Mol Pharmacol"},{"key":"337387_CR2","first-page":"6936","volume":"50","author":"JW Jaroszewski","year":"1990","unstructured":"Jaroszewski JW, Kaplan O, Cohen JS: Action of gossypol and rhodamine 123 on wild type and multidrug resistant MCF-7 human breast cancer cell 31P nuclear magnetic resonance and toxicity studies. Cancer Res 50: 6936-6943, 1990","journal-title":"Cancer Res"},{"key":"337387_CR3","first-page":"768","volume":"44","author":"GP Tuszynski","year":"1984","unstructured":"Tuszynski GP, Cossu G: Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma and other tissue culture cell lines. Cancer Res 44: 768-771, 1984","journal-title":"Cancer Res"},{"key":"337387_CR4","first-page":"35","volume":"44","author":"Y-C Wang","year":"1984","unstructured":"Wang Y-C, Rao PN: Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro. Cancer Res 44: 35-38, 1984","journal-title":"Cancer Res"},{"issue":"4","key":"337387_CR5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0167-4781(86)90051-5","volume":"886","author":"LJ Rosenberg","year":"1986","unstructured":"Rosenberg LJ, Adlakha RC, Desai DM, Rao PN: Inhibition of DNA polymerase alpha by gossypol. Biochim Biphys Acta 886(4): 258-267, 1986","journal-title":"Biochim Biphys Acta"},{"issue":"8","key":"337387_CR6","first-page":"2052","volume":"49","author":"RC Adlakha","year":"1989","unstructured":"Adlakha RC, Aschorn CL, Chan D, Zwelling LA: Modulation of 4'-(9-acrinidylamino) methanesulfon-m-anisided-induced topoisomerase II medicated DNA cleavage by gossypol. Cancer Res 49(8): 2052-2058, 1989","journal-title":"Cancer Res"},{"key":"337387_CR7","first-page":"20","volume":"15","author":"PN Rao","year":"1985","unstructured":"Rao PN, Wang Y-C, Lotzova E, Khan AA, Rao SP, Stephens LC: Antitumor effects of gossypol on murine tumors. Cancer Chemother Pharmacol 15: 20-25, 1985","journal-title":"Cancer Chemother Pharmacol"},{"key":"337387_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3835(84)90021-1","volume":"24","author":"WW Tso","year":"1984","unstructured":"Tso WW: Gossypol inhibits Ehrlich ascites tumor cell proliferation. Cancer Lett 24: 257, 1984","journal-title":"Cancer Lett"},{"key":"337387_CR9","first-page":"725","volume":"4","author":"JM Varley","year":"1989","unstructured":"Varley JM, Armour J, Swallow JE, Jefferys AJ, Ponder BAJ, T'Ang A, Fung YKT, Brammar WJ, Walker RA: The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumors. Oncogene 4: 725-729, 1989","journal-title":"Oncogene"},{"key":"337387_CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.3175651","volume":"242","author":"A T'Ang","year":"1988","unstructured":"T'Ang A, Varley JM, Chakraborty S, Muphree L, Fung YKT: Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242: 263-266, 1988","journal-title":"Science"},{"key":"337387_CR11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0092-8674(89)90495-9","volume":"58","author":"JA Cooper","year":"1989","unstructured":"Cooper JA, Whyte P: Rb and the cell cycle: Entrance or exit? Cell 58: 1009-1011, 1989","journal-title":"Cell"},{"key":"337387_CR12","first-page":"707","volume":"9","author":"J Lukas","year":"1994","unstructured":"Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9: 707-718, 1994","journal-title":"Oncogene"},{"key":"337387_CR13","first-page":"2127","volume":"8","author":"MF Buckley","year":"1993","unstructured":"Buckley MF, Sweeney JKE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993","journal-title":"Oncogene"},{"key":"337387_CR14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1073\/pnas.90.3.1112","volume":"90","author":"K Keyomarsi","year":"1993","unstructured":"Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci 90: 1112-1116, 1993","journal-title":"Proc Natl Acad Sci"},{"key":"337387_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006103831990","volume":"52","author":"DM Barnes","year":"1998","unstructured":"Barnes DM, Gillett CE: Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1-15, 1998","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"337387_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1997.330","volume":"76","author":"M Ligueros","year":"1997","unstructured":"Ligueros M, Jeoung D, Tang B, Hochhauser D, Reidenberg MM, Sonenberg M: Gossypol inhibition of mitosis, cyclin D1, and Rb protein in human mammary cancer cells and cyclin D1 transfected human fibrosarcoma cells. Br J Cancer 76(1): 21-28, 1997","journal-title":"Br J Cancer"},{"key":"337387_CR17","first-page":"305","volume-title":"Reproductive Medicine: A Millennium Review","author":"MM Reidenberg","year":"1999","unstructured":"Reidenberg MM: Studies of gossypol in the treatment of cancer. In: Elsimer M, Coutinho, Paulo Spinola (eds) Reproductive Medicine: A Millennium Review. Parthenon Pub. Group, New York, 1999, pp 305-308"},{"key":"337387_CR18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00685601","volume":"30","author":"RC Stein","year":"1992","unstructured":"Stein RC, Joseph AEA, Matlin SA, Cunningham D, Ford HT, Coombes RC: A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother Pharmacol 30: 480-482, 1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"337387_CR19","first-page":"1019","volume":"76","author":"MR Flack","year":"1993","unstructured":"Flack MR, Pyle RG, Mullen NM, Lorenzo B, Wu YW, Knazek RA, Nisula BC, Reidenberg MM: Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 76: 1019-1024, 1993","journal-title":"J Clin Endocrinol Metab"},{"key":"337387_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1006267902186","volume":"43","author":"P Bushunow","year":"1999","unstructured":"Bushunow P, Reidenberg M, Wasenko J, Winfield J, Lorenzo B, Lemke S, Himpler B, Corona R, Coyle T: Gossypol treatment of recurrent adult malignant gliomas. J Neuro-Oncol 43: 79-86, 1999","journal-title":"J Neuro-Oncol"},{"key":"337387_CR21","doi-asserted-by":"crossref","unstructured":"Gehan E: The determination of the number of patients required in a preliminary and follow up trial of a new chemotherapeutic agent. J Chronic Diseases 1061, 13: 346-353","DOI":"10.1016\/0021-9681(61)90060-1"},{"issue":"1","key":"337387_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0024-3205(95)00243-Y","volume":"57","author":"NE Gilbert","year":"1995","unstructured":"Gilbert NE, O'Reilly JE, Ghange CJG, Lin YC, Brueggmeier RW: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci 57(1): 61-67, 1995","journal-title":"Life Sci"},{"key":"337387_CR23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00008390-199710000-00002","volume":"7","author":"L Blackstaffe","year":"1997","unstructured":"Blackstaffe L, Shelley MD, Fish RG: Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell lines. Mel Res 7: 364-372, 1997","journal-title":"Mel Res"},{"key":"337387_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006103831990","volume":"52","author":"DM Barnes","year":"1998","unstructured":"Barnes DM, Gillet CE: Cyclin D1 and breast cancer. Breast Cancer Res Treat 52: 1-15, 1998","journal-title":"Breast Cancer Res Treat"},{"key":"337387_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3835(98)00302-4","volume":"135","author":"MD Shelley","year":"1999","unstructured":"Shelley MD, Hartley L, Fish RG, Groundwater P, Morgan JJG, Mort A, Mason M, Evans A: Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. Cancer Lett 135: 171-180, 1999","journal-title":"Cancer Lett"},{"key":"337387_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0090-8258(89)90623-9","volume":"32","author":"V Band","year":"1989","unstructured":"Band V, Hoffer AP, Band Rhinehardt AE, Knapp RC, Matlin SA, Anderson DJ: Anti-proliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol Oncol 32: 273-277, 1989","journal-title":"Gynecol Oncol"},{"key":"337387_CR27","first-page":"1291","volume":"13","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, Kulp SK, Sugimoto Y, Brueggemeier RW, Lin YC: The (-)-enantiomer of gossypol inhibits proliferation of stromal cells derived from human breast adipose tissues by enhancing transforming growth factor Beta 1 production. Int J Oncol 13: 1291-1297, 1998","journal-title":"Int J Oncol"},{"key":"337387_CR28","first-page":"1901","volume":"3","author":"L Sreerama","year":"1997","unstructured":"Sreerama L, Sladek NE: Cellular levels of class 1 and class 3 aldehyde dehydrogenases and certain other drug-metabolizing enzymes in human breast malignancies. Clin Cancer Res 3: 1901-1914, 1997","journal-title":"Clin Cancer Res"},{"key":"337387_CR29","first-page":"122","volume-title":"Enzymology and Molecular Biology of Carbonyl Metabolism 6","author":"GK Rekha","year":"1996","unstructured":"Rekha GK, Sladek NE: Inhibition of Human Class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amount of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol. Advances in Experimental medicine and biology. In: Weiner et al. (eds), Enzymology and Molecular Biology of Carbonyl Metabolism 6. Vol 414. Plenum Press, New York, 1996, pp 122-146"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010686204736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1010686204736\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1010686204736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010686204736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:15:40Z","timestamp":1750464940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1010686204736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["337387"],"URL":"https:\/\/doi.org\/10.1023\/a:1010686204736","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}